Results 131 to 140 of about 115,977 (260)

Role of immunoturbidimetric plasma fibrin D-dimer test in patients with coronary artery disease as well as ischemic heart disease in emergency medicine [PDF]

open access: yes, 2011
The aim of the present was to assess the value of the ELISA D-dimer (hemostatic marker) assay in patients with coronary artery disease as well as ischemic heart disease presenting to the emergency department with chest pain syndrome. Methods: We measured
Ajay K. Singh , Vikas Gupta, Neelima Singh, Sanjeev K. Singh , Nivedita Singh, Arun Raiza, Harshverdhan Singh , Int J Cur Biomed Phar Res.
core  

Technological Advancements in Carotenoid‐Based Encapsulated Systems: Emerging Trends in Health‐Promoting Benefits and Their Role in Nutrient Delivery

open access: yeseFood, Volume 6, Issue 6, December 2025.
Encapsulation has emerged as a promising strategy to enhance carotenoid stability, bioavailability, and antioxidant capacity. This technique involves enclosing carotenoids within protective materials at the micro or nanoscale, protecting against environmental, processing, and gastrointestinal stresses.
Mian Shamas Murtaza   +9 more
wiley   +1 more source

Dietary Index for Gut Microbiota and Leisure Time Physical Activity: The Potential Combined Protective Impact on Hypertension Risk

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
Joint associations of dietary index for gut microbiota and leisure‐time physical activity with hypertension risk in U.S. adults. ABSTRACT Emerging evidence highlights the gut microbiome's role in hypertension via microbial metabolites and endothelial dysfunction, while the Dietary Index for Gut Microbiota (DI‐GM) quantifies diet quality for microbiota ...
Jiaxin Wang   +6 more
wiley   +1 more source

Dynamics of proinflammatory cytokines level in stable angina (II–III functional class)

open access: yesСеченовский вестник, 2016
The article discusses the evaluation of cytokine level (IL-1β, IL-6) in patients with II–III functional class stable angina. In the group of patients with II–III class stable angina, the standard therapy failed to normalize the level of proinflammatory ...
E. K. Gordeeva, A. H. Kade, S. A. Zanin
doaj  

Association Between History of Rhythm Control Therapy and Clinical Outcomes in Atrial Fibrillation Patients With Stable Coronary Artery Disease: A Sub‐Analysis of the AFIRE Trial

open access: yesJournal of Arrhythmia, Volume 41, Issue 6, December 2025.
In the AFIRE study, 27% of patients had a history of rhythm control therapy. While unadjusted analyses suggested a benefit, propensity score‐matched results showed no significant difference in the primary efficacy outcome between patients with and without such history.
Daisuke Wakatsuki   +13 more
wiley   +1 more source

Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data [PDF]

open access: gold, 2018
Ieva Briede   +9 more
openalex   +1 more source

Clinical Profiles and In‐Hospital Outcomes of Pre‐Existing Versus Newly Diagnosed Atrial Fibrillation in Coronary Care Units: Insights From the MORCOR‐TURK National Registry

open access: yesJournal of Arrhythmia, Volume 41, Issue 6, December 2025.
MORCOR‐TURK National Registry Study: In Turkish coronary care units, newly diagnosed atrial fibrillation, compared with pre‐existing AF, is associated with a higher inflammatory burden (CRP 28.4 vs. 12.6 mg/L), elevated NT‐proBNP levels, and approximately double the in‐hospital mortality (12.0% vs. 6.8%).
Ertan Aydin   +8 more
wiley   +1 more source

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT

open access: yesРоссийский кардиологический журнал, 2009
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak   +5 more
doaj  

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies

open access: yesAlimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1192-1201, December 2025.
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj   +6 more
wiley   +1 more source

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

open access: yesCardiology and Therapy
Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice ...
Luís Henrique Wolff Gowdak   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy